Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Idiopathic Retinal Telangiectasia”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Large-scale testing (Phase 3)WithdrawnNCT00406380
What this trial is testing

Effect of Avastin in Juxtafoveal Telangiectasias

Who this might be right for
Telangiectasis
Asociación para Evitar la Ceguera en México
Testing effectiveness (Phase 2)Study completedNCT03669393
What this trial is testing

Evaluate THR-317 Treatment for Macular Telangiectasia Type 1 (MacTel 1)

Who this might be right for
Retinal TelangiectasisIdiopathic Juxtafoveal Retinal Telangiectasia
ThromboGenics 8
Testing effectiveness (Phase 2)Study completedNCT01205035
What this trial is testing

High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia

Who this might be right for
Retinal DiseasesTelangiectasis
Eye Center of Northern Colorado, P.C. 6
Large-scale testing (Phase 3)Study completedNCT00451763
What this trial is testing

Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia

Who this might be right for
RetinaTelangiectasis
University of Sao Paulo 31
Not applicableLooking for participantsNCT01793168
What this trial is testing

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Who this might be right for
Rare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more
Sanford Health 20,000
Early research (Phase 1)Study completedNCT00457145
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia Without New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Early research (Phase 1)Study completedNCT00457067
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Not applicableStudy completedNCT01354093
What this trial is testing

The Role of Macular Pigment Carotenoids in the Pathogenesis and Treatment of Macular Telangiectasia Type 2 (MacTel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Paul S. Bernstein 8
Early research (Phase 1)Study completedNCT01327911
What this trial is testing

Ciliary Neurotrophic Factor (CNTF) Safety Trial in Patients With Macular Telangiectasia (Mactel)

Who this might be right for
Idiopathic Juxtafoveal Telangiectasia
Neurotech Pharmaceuticals 7